Latest News & Updates
Breaking News
3 hours ago
Vaibhavi M.
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Chemomab And Scipher Medicine Merge To Advance Nebokitug In Rheumatoid Arthritis Deal Secures $30 Million
Chemomab and Scipher Medicine merge in an all-stock deal with $30M in new financing to advance nebokitug into Phase 2 for rheumatoid arthritis, with topline data expected in H1 2028.
Vaibhavi M.
Tarsus Pharmaceuticals Acquires iRenix Medical To Advance IRX-101 Ocular Antiseptic, Expands Ophthalmology Pipeline With $75 Million
Tarsus Pharmaceuticals acquires iRenix Medical for $75M, adding IRX-101 ocular antiseptic to its pipeline after Phase 2b/3 data showed 50% pain reduction in intravitreal injection patients.
Vaibhavi M.
Aura Biosciences Appoints Jeremy Bender To Board of Directors, Strengthens Board With Oncology Executive
Aura Biosciences appoints Jeremy Bender to its Board as Bel-Sar advances toward regulatory approval in choroidal melanoma with Phase 3 CoMpass trial enrollment now complete.
Vaibhavi M.
Ipsen Achieves Positive Phase III Results for Dysport in Both Episodic and Chronic Migraine
Ipsen's Dysport meets primary endpoints in both E-BEOND and C-BEOND Phase III trials, signaling a likely regulatory submission for a broader migraine indication.
Pharma Now Editorial Team
